Novavax Inc. (NVAX) released Loss for its third quarter that increased from the same period last year and missed the Street estimates.
The company's bottom line totaled -$202.379 million, or -$1.25 per share. This compares with -$121.300 million, or -$0.76 per share, last year.
Analysts on average had expected the company to earn -$0.92 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 16.6% to $70.445 million from $84.512 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings: -$202.379 Mln. vs. -$121.300 Mln. last year.-EPS: -$1.25 vs. -$0.76 last year.-Revenue: $70.445 Mln vs. $84.512 Mln last year.
Looking ahead, for the full year, Novavax has revised up its revenue outlook in line with analysts' forecast.
Excluding items, the company now expects total revenue of $1.040 billion to $1.060 billion, higher than the earlier guidance of $1 billion to $1.050 billion. Analysts, on average, forecast the firm to report revenue of $1.05 billion for the year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.